Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
Abstract of corresponding document: WO 9009186 (A1) A pharmaceutical preparation in the prophylaxis against and/or the treatment of beta -streptococcal tonsillitis is described. The preparation includes at least one viable microorganism strain selected from the group consisting of Streptococcus sanguis II strains with the deposit numbers NCIB 40104, NCIB 40105 and NCIB 40106, the Streptococcus mitis strain with the deposit number NCIB 40107 and streptococci strains with essentially the same capacity to inhibit beta -streptococci as the deposited strains, in a pharmaceutically acceptable medium wherein the microorganisms retain their viability. Use of the preparation in the prophylaxis against and/or the treatment of beta -streptococcal tonsillitis is also described.
JO19901737A1990-03-011990-03-01Pharmaceutical preparation in the treatment of tonsillitis
JO1737B1
(en)
Method for eliminating staphylococcus aureus, novel microorganism of genus brachybacterium, and care garment, care sheet or care bedclothes, each being immobilized with microorganism of genus brachybacterium
New Clue to the Cause of Toxic Shock: Acquisition of viral DNA by Staphylococcus aureus may enable this bacterium to produce toxins that cause the symptoms of toxic shock
Antibiotics designated as bm 782 alpha 1, bm 782 alpha 2 and bm 782 alpha 1a, process for their preparation and pharmaceutical compositions containing them